OPIANT PHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Outstanding from Q2 2011 to Q3 2022

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Opiant Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q2 2011 to Q3 2022.
  • Opiant Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2022 was 5.16M shares, a 11.8% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 5.16M +547K +11.8% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 5.12M +773K +17.8% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 5.08M +749K +17.3% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 4.91M +652K +15.3% Dec 31, 2021 10-Q 2022-11-14
Q3 2021 4.62M +360K +8.46% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 4.35M +91.5K +2.15% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 4.33M +72.5K +1.7% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 4.26M +71.7K +1.71% Dec 31, 2020 10-K 2022-03-15
Q3 2020 4.26M +183K +4.5% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 4.26M +233K +5.78% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 4.26M +333K +8.48% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 4.19M +341K +8.87% Dec 31, 2019 10-K 2021-03-04
Q3 2019 4.07M +279K +7.36% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 4.03M +1.31M +48.5% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 3.93M +1.34M +51.7% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 3.85M +1.31M +51.6% Dec 31, 2018 10-K 2020-03-04
Q3 2018 3.8M +1.76M +86.2% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 2.71M +685K +33.8% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 2.59M +566K +28% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 2.54M +528K +26.3% Dec 31, 2017 10-K 2019-03-21
Q3 2017 2.04M +45.5K +2.28% Oct 31, 2017 10-Q 2017-12-04
Q2 2017 2.03M +34.2K +1.72% Jul 31, 2017 10-K 2019-03-21
Q1 2017 2.02M +38.9K +1.97% Apr 30, 2017 10-Q 2017-06-14
Q4 2016 2.01M +121K +6.41% Jan 31, 2017 10-Q 2017-03-15
Q3 2016 1.99M +127K +6.8% Oct 31, 2016 10-Q 2016-12-15
Q2 2016 1.99M +151K +8.18% Jul 31, 2016 10-KT 2018-03-07
Q1 2016 1.98M +154K +8.45% Apr 30, 2016 10-Q 2016-06-08
Q4 2015 1.89M +66.9K +3.68% Jan 31, 2016 10-Q 2016-03-15
Q3 2015 1.87M -177M -99% Oct 31, 2015 10-Q 2015-12-14
Q2 2015 1.84M +59.8K +3.36% Jul 31, 2015 10-K 2016-10-28
Q1 2015 1.83M -176M -99% Mar 12, 2015 10-K 2015-10-26
Q4 2014 1.82M -176M -99% Dec 31, 2014 10-K 2016-10-28
Q3 2014 179M +10.6M +6.28% Oct 31, 2014 10-Q 2014-12-09
Q2 2014 1.78M -163M -98.9% Jul 31, 2014 10-K 2015-10-26
Q1 2014 178M +32.4M +22.2% Apr 30, 2014 10-Q 2014-06-10
Q4 2013 178M +45.4M +34.2% Jan 31, 2014 10-Q 2014-03-17
Q3 2013 168M +37.8M +28.9% Oct 31, 2013 10-Q 2013-12-16
Q2 2013 165M +38.6M +30.6% Jul 31, 2013 10-K 2014-10-27
Q1 2013 146M +28.5M +24.3% Apr 30, 2013 10-Q 2013-06-14
Q4 2012 133M +28.4M +27.2% Jan 31, 2013 10-Q 2013-03-18
Q3 2012 131M +38.6M +42% Oct 31, 2012 10-Q 2012-12-20
Q2 2012 126M +49.1M +63.8% Jul 31, 2012 10-K 2013-10-29
Q1 2012 117M Apr 30, 2012 10-Q 2012-06-14
Q4 2011 104M Jan 31, 2012 10-Q 2012-03-16
Q3 2011 92M Oct 31, 2011 10-Q 2011-12-15
Q2 2011 77M Jul 31, 2011 10-K/A 2012-11-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.